Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MAST Study - Metformin in Reducing Progression Among Men on Expectant Management for Low-Risk Prostate Cancer"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Neil Fleshner
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Neil Fleshner
183 views
June 11, 2024
Chapters
MAST Study Overview & Metformin's Role
00:00
Trial Design & Patient Demographics
01:06
Primary Outcome & Therapeutic Progression
02:57
Subgroup Analysis & Unexpected Findings
04:08
Conclusions & Future Directions
06:02
Comments 0
Login to view comments.
Click here to Login